Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026
The “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at 6:30 PM CEST (8:30 PM AMT). Part of the ESMO Therapeutic Landscapes series, the session will focus on recognising, preventing, and managing toxicities associated with […]